Filing Details
- Accession Number:
- 0000899243-18-014190
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-05-29 06:52:13
- Reporting Period:
- 2018-05-25
- Accepted Time:
- 2018-05-29 06:52:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1427925 | Acelrx Pharmaceuticals Inc | ACRX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1628970 | Raffi Asadorian | C/O Acelrx Pharmaceuticals, Inc. 351 Galveston Drive Redwood City CA 94063 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-05-25 | 5,000 | $3.18 | 27,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Balance includes non-reportable acquisition of 10,000 shares of Common Stock through the Company's Employee Stock Purchase Plan.
Billionaire Hedge Funds
